Milan, Italy

Roberto Villa

This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roberto Villa. Retrieved from https://idiyas.com/inventor/roberto-villa-ldu0f7ux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roberto Villa

Introduction

Roberto Villa is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular disorders. His work has led to the development of innovative compounds that aim to improve patient outcomes.

Latest Patents

Roberto Villa holds 1 patent for his invention titled "14-deoxy-14.alpha.-cardenolides 3.beta.-thioderivatives and pharmaceutical compositions comprising same for treating cardiovascular disorders, such as heart failure and hypertension." This patent highlights his commitment to addressing critical health issues through scientific innovation.

Career Highlights

Villa is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., a company known for its focus on pharmaceutical advancements. His role in this organization has allowed him to contribute to the development of essential medical treatments.

Collaborations

Throughout his career, Roberto Villa has collaborated with esteemed colleagues, including Mauro Gobbini and Luigi Bernardi. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Roberto Villa's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing health challenges. His work continues to inspire advancements in cardiovascular treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…